Abdera Comes Out Of Stealth With Radiopharmaceutical-Specialized Antibody Approach

Abdera came out of stealth with $142m in venture capital financing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business